Fifth Third Bancorp’s abrdn Life Sciences Investors HQL Stock Holding History

Fifth Third Bancorp’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$36.1K	Buy	1,804 +930	+106%	+$16.4K	﹤0.01%	3356
2026 Q1	$14.2K	Buy	+874	New	+$14.6K	﹤0.01%	3607
2022 Q2	–	Sell	-5	Closed	–	–	2713
2022 Q1	$0	Buy	5 +3	+150%	+$52	﹤0.01%	2717
2021 Q4	$0	Hold	2	–	–	﹤0.01%	2723
2021 Q3	$0	Hold	2	–	–	﹤0.01%	2693
2021 Q2	$0	Hold	2	–	–	﹤0.01%	2470
2021 Q1	$0	Sell	2 -114	-98%	-$2.35K	﹤0.01%	2448
2020 Q4	$2K	Buy	+116	New	+$2.14K	﹤0.01%	2224
2015 Q1	–	Sell	-1,104	Closed	-$27K	–	2829
2014 Q4	$27K	Buy	1,104 +20	+2%	+$480	﹤0.01%	1625
2014 Q3	$24K	Buy	1,084 +20	+2%	+$434	﹤0.01%	1702
2014 Q2	$22K	Buy	1,064 +542	+104%	+$11.4K	﹤0.01%	1773
2014 Q1	$11K	Buy	522 +9	+2%	+$200	﹤0.01%	1964
2013 Q4	$10K	Hold	513	–	–	﹤0.01%	1835
2013 Q3	$10K	Buy	+513	New	+$9.82K	﹤0.01%	1871

Other funds holding HQL

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCM

Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

NIM

Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Fifth Third Bancorp's HQL Position: Q2 2026 in Review

Fifth Third Bancorp increased its abrdn Life Sciences Investors (HQL) stake by 106% in Q2 2026, buying an estimated $16.4K and bringing the position to 1,804 shares worth $36.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3356.

Fifth Third Bancorp first reported a position in HQL in Q3 2013 and has held it in 14 quarters since. 83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

Fifth Third Bancorp held 1,804 shares of abrdn Life Sciences Investors worth $36.1K as of Q2 2026.
Fifth Third Bancorp bought 930 abrdn Life Sciences Investors shares in Q2 2026, an estimated $16.4K.
abrdn Life Sciences Investors made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3356 holding.
Fifth Third Bancorp first reported a position in abrdn Life Sciences Investors in Q3 2013 and has held it in 14 quarters since.
83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.